Embryonic Stem Cell Superiority Myth is Crumbling

With the exception of the Missouri media and perhaps, the New York Times, it is now clear that adult stem cells offer tremendous hope for treatments for a wide variety of ailments. The Journal of the American Medical Association reports some good news. From a video presentation:

Adult stem cell therapy has become a standard of care when treating several types of cancer. Now a review of clinical trials involving adult stem cells during the past ten years indicates they are helping patients who have a variety of diseases and even heart trouble. One patient diagnosed with multiple sclerosis says his symptoms are gone. Jennifer Mitchell explains in this week’s JAMA Report…

Dr. Richard Burt and his colleagues at Northestern University reviewed the outcomes of about twenty-five hundred patients who had stem cell transplants. They found the cells appear to be putting some patients with autoimmune diseases into remission and are offering some improvement in heart patients who have suffered heart attacks… AUDIO:”It’s a whole new approach to these diseases. Rather than just surgery or drugs that you can use, a cellular approach that seems in many different studies to be benefitting the patient.” …

AUDIO:BARRY NOW LEADS AN ACTIVE LIFESTYLE. HERE HE IS WITH THE ICE HOCKEY TEAM HE COACHES. AUDIO:”I’ve had five years of good life. Five years. If I didn’t do the transplant I would probably be in a wheelchair today.”

Remember when embryonic stem cells were going to be a huge issue in the 2008 election? Where are the critics now?

Next
YOU MIGHT ALSO LIKE

How the State Failed Noelia Castillo

Itxu Díaz

On March 26, Noelia Castillo, a twenty-five-year-old Spanish woman, was killed by her doctors at her own…

The Mind’s Profane and Sacred Loves

Algis Valiunas

The teachers you have make all the difference in your life. That they happened to come into…

History’s Pro Tips on Iran

Francis X. Maier

Nothing in human experience compares to the wars of the last 120 years. Their scope has grown…